ANTI-TUMOR NECROSIS FACTOR THERAPY

Open Access
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study
John D. Reveille, Atul Deodhar, Paul H. Caldron, Anna Dudek, Diane D. Harrison, Lilianne Kim, Kim Hung Lo, Jocelyn H. Leu and Elizabeth C. Hsia

The Journal of Rheumatology October 1 2019, 46 (10) 1277-1283; DOI: https://doi.org/10.3899/jrheum.180718
Open Access
Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study
Frank Behrens, Michaela Koehm, Uta Arndt, Bianca M. Wittig, Gerd Greger, Diamant Thaçi, Eva Scharbatke, Hans-Peter Tony and Harald Burkhardt

The Journal of Rheumatology March 1 2016, 43 (3) 632-639; DOI: https://doi.org/10.3899/jrheum.141596
You have access
Reduction of Inflammation Drives Lipid Changes in Ankylosing Spondylitis
Sjoerd C. Heslinga, Mike J. Peters, Marieke M. ter Wee, Irene E. van der Horst-Bruinsma, Alper M. van Sijl, Yvo M. Smulders and Michael T. Nurmohamed

The Journal of Rheumatology October 1 2015, 42 (10) 1842-1845; DOI: https://doi.org/10.3899/jrheum.150193
You have access
Is Etanercept 25 mg Once Weekly as Effective as 50 mg at Maintaining Response in Patients with Ankylosing Spondylitis? A Randomized Control Trial
Max Yates, Louise E. Hamilton, Frances Elender, Loretta Dean, Helen Doll, Alex J. MacGregor, Joegi Thomas and Karl Gaffney

The Journal of Rheumatology July 1 2015, 42 (7) 1177-1185; DOI: https://doi.org/10.3899/jrheum.141335
You have access
Performance of the Tuberculin Skin Test and Interferon-γ Release Assays: An Update on the Accuracy, Cutoff Stratification, and New Potential Immune-based Approaches
Delia Goletti, Alessandro Sanduzzi and Giovanni Delogu

The Journal of Rheumatology Supplement May 1 2014, 91 24-31; DOI: https://doi.org/10.3899/jrheum.140099

Main menu

User menu

Search

ANTI-TUMOR NECROSIS FACTOR THERAPY

Content

Resources

Subscribers

More